Vistagen Therapeutics, Inc. (VTGN)

NASDAQ: VTGN · Real-Time Price · USD

3.755

-0.265 (-6.59%)

Nov 7, 2025, 1:18 PM EST - Market open

Vistagen Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Nov '25 Nov 7, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	115	72	143	27	256	305	Upgrade
Market Cap Growth	41.88%	-49.43%	421.73%	-89.32%	-16.12%	1309.99%	Upgrade
Enterprise Value	63	-15	18	5	176	211	Upgrade
Last Close Price	4.02	2.50	5.28	3.74	37.20	63.90	Upgrade
PS Ratio	194.21	148.47	134.11	-120.48	230.95	280.23	Upgrade
PB Ratio	2.07	1.02	1.25	2.26	3.96	3.11	Upgrade
P/TBV Ratio	2.17	1.02	1.25	2.26	3.96	3.32	Upgrade
EV/Sales Ratio	96.77	-	17.28	-	158.30	193.50	Upgrade
Debt / Equity Ratio	0.04	0.02	0.02	0.22	0.05	0.04	Upgrade
Asset Turnover	0.01	0.01	0.02	-	0.01	0.02	Upgrade
Quick Ratio	5.66	6.38	23.26	3.64	11.88	24.62	Upgrade
Current Ratio	5.98	6.51	23.56	3.83	12.32	24.86	Upgrade
Return on Equity (ROE)	-69.05%	-55.68%	-46.47%	-154.30%	-58.62%	-36.78%	Upgrade
Return on Assets (ROA)	-40.86%	-33.64%	-28.52%	-77.39%	-32.65%	-19.66%	Upgrade
Return on Capital (ROIC)	-44.94%	-37.16%	-31.46%	-89.75%	-35.19%	-21.28%	Upgrade
Earnings Yield	-45.23%	-71.26%	-20.58%	-216.63%	-18.65%	-5.87%	Upgrade
FCF Yield	-40.77%	-58.61%	-18.13%	-182.55%	-17.75%	-4.04%	Upgrade
Buyback Yield / Dilution	-23.99%	-59.53%	-178.13%	-5.45%	-129.85%	-96.34%	Upgrade

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q